Congress trades
Exact Sciences Corporation (EXAS)
About Exact Sciences Corporation
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Kevin T. Conroy
- Employees
- 6,900
- Listed since
- Feb 1, 2001
- Market value
- $20.0B
- Price to earnings
- -
- Earnings per share
- -$1.10
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2025reported Feb 13, 2026 | -$0.45 | -$0.11 | $878.4M | $860.9M | EPS missRevenue beat |
| Q3 FY2025reported Nov 3, 2025 | $0.24 | -$0.06 | $850.7M | $810.5M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | $0.22 | -$0.02 | $811.1M | $810.1M | EPS beatRevenue in line |
| Q1 FY2025reported May 1, 2025 | -$0.54 | -$0.37 | $706.8M | $688.6M | EPS missRevenue beat |
| Q4 FY2024reported Feb 19, 2025 | -$0.06 | -$0.29 | $713.4M | $697.9M | EPS beatRevenue beat |
| Q3 FY2024reported Nov 5, 2024 | -$0.21 | -$0.20 | $708.7M | $716.8M | EPS missRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2024 · proxy filed Apr 29, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Kevin ConroyChairman, President and Chief Executive Officer | $1.1M | $13.5M | $960K | $15.5M |
| Aaron BloomerExecutive Vice President and Chief Financial Officer | $432K | $6.0M | $752K | $7.2M |
| Jacob OrvilleExecutive Vice President and General Manager, Screenin | $618K | $3.6M | $234K | $4.4M |
| Brian BaranickExecutive Vice President and General Manager, Precisio | $600K | $3.6M | $218K | $4.4M |
| Sarah CondellaExecutive Vice President, Human Resources | $509K | $1.9M | $226K | $2.6M |
The summary compensation table from the 2024 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in EXAS
20 disclosures of 28 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | n/a | Mar 24, 2026 | Apr 3, 2026 | 10d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +96.1%S&P +24.9% · vs S&P 500 +71.2% | May 10, 2024 | Jun 8, 2024 | 29d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +64.1%S&P +33.0% · vs S&P 500 +31.1% | Feb 1, 2024 | Mar 7, 2024 | 35d |
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | +42.2%S&P +37.8% · vs S&P 500 +4.4% | Jan 2, 2024 | Feb 11, 2024 | 40d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +77.0%S&P +47.8% · vs S&P 500 +29.2% | Nov 13, 2023 | Dec 8, 2023 | 25d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +56.8%S&P +49.3% · vs S&P 500 +7.5% | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +36.8%S&P +46.3% · vs S&P 500 -9.5% | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +65.5%S&P +56.6% · vs S&P 500 +8.8% | May 1, 2023 | Jun 11, 2023 | 41d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +53.8%S&P +64.4% · vs S&P 500 -10.6% | Jan 20, 2023 | Feb 17, 2023 | 28d |
| Kevin HernJoint | Stock | Sale | $1,001 - $15,000 | +55.4%S&P +60.1% · vs S&P 500 -4.7% | Jan 31, 2023 | Feb 14, 2023 | 14d |
| Kevin HernJoint | Stock | Sale | $50,001 - $100,000 | +109.8%S&P +70.5% · vs S&P 500 +39.4% | Dec 19, 2022 | Jan 13, 2023 | 25d |
| Kevin HernDependent child | Stock | Sale | $1,001 - $15,000 | +107.5%S&P +62.6% · vs S&P 500 +45.0% | May 16, 2022 | Jun 14, 2022 | 29d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -2.8%S&P +55.3% · vs S&P 500 -58.1% | Jun 3, 2021 | Jul 15, 2021 | 42d |
| Kevin HernJoint | Stock | Purchase | $50,001 - $100,000 | -0.8%S&P +56.6% · vs S&P 500 -57.4% | May 20, 2021 | Jun 15, 2021 | 26d |
| Kevin HernDependent child | Stock | Purchase | $1,001 - $15,000 | -0.8%S&P +56.6% · vs S&P 500 -57.4% | May 20, 2021 | Jun 15, 2021 | 26d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -15.0%S&P +82.5% · vs S&P 500 -97.5% | Nov 11, 2020 | Dec 9, 2020 | 28d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -1.6%S&P +91.8% · vs S&P 500 -93.3% | Oct 26, 2020 | Nov 5, 2020 | 10d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +37.2%S&P +91.3% · vs S&P 500 -54.1% | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Kevin HernJoint | Stock | Purchase | $1,001 - $15,000 | +8.8%S&P +101.4% · vs S&P 500 -92.5% | Jul 27, 2020 | Aug 15, 2020 | 19d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +21.7%S&P +111.1% · vs S&P 500 -89.4% | Jun 2, 2020 | Jul 9, 2020 | 37d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded EXAS?
Kevin Hern, Josh Gottheimer disclosed EXAS transactions in the filings shown here.
How quickly are EXAS trades disclosed?
Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.